Literature DB >> 20596889

Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population.

Jing Zhang1, James D Fackenthal, Dezheng Huo, Yonglan Zheng, Olufunmilayo I Olopade.   

Abstract

BRCA1/2 germline mutations predispose to breast and ovarian cancer. Large genomic rearrangements (LGRs) have widened the mutational spectrum of the BRCA1 gene, but the frequencies vary in different populations. In this study, we want to determine the spectrum of LGRs in BRCA1 gene in Nigerian breast cancer patients. The multiplex ligation-dependent probe amplification (MLPA) assay was used to screen BRCA1 rearrangements in 352 patients who previously tested negative for BRCA1 and BRCA2 point mutations and small insertions/deletions. Positive MLPA result was confirmed and located by long-range PCR. The breakpoints of the candidate rearrangement were characterized by sequencing. A novel deletion of BRCA1 exon 21 (c.5277 + 480_5332 + 672del) was detected in 1 out of 352 Nigerian breast cancer patients (0.3% occurrence frequency). Further analysis of breakpoints revealed that the deletion involves two Alu-elements: one AluSg in intron 20 and the AluY in intron 21. These data suggest that while BRCA1 genomic rearrangement exists, they do not contribute significantly to BRCA1-associated risk in the Nigerian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596889     DOI: 10.1007/s10549-010-1006-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Detection of false positive mutations in BRCA gene by next generation sequencing.

Authors:  Moushumi Suryavanshi; Dushyant Kumar; Manoj Kumar Panigrahi; Meenakshi Chowdhary; Anurag Mehta
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 2.  Triple-negative breast cancer in African-American women: disparities versus biology.

Authors:  Eric C Dietze; Christopher Sistrunk; Gustavo Miranda-Carboni; Ruth O'Regan; Victoria L Seewaldt
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

3.  BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan.

Authors:  Ida Biunno; Gitana Aceto; Khalid Dafaallah Awadelkarim; Annalisa Morgano; Ahmed Elhaj; Elgaylani Abdalla Eltayeb; Dafalla Omer Abuidris; Nasr Eldin Elwali; Chiara Spinelli; Pasquale De Blasio; Ermanna Rovida; Renato Mariani-Costantini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

4.  BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.

Authors:  Tara M Friebel; Irene L Andrulis; Judith Balmaña; Amie M Blanco; Fergus J Couch; Mary B Daly; Susan M Domchek; Douglas F Easton; William D Foulkes; Patricia A Ganz; Judy Garber; Gord Glendon; Mark H Greene; Peter J Hulick; Claudine Isaacs; Rachel C Jankowitz; Beth Y Karlan; Judy Kirk; Ava Kwong; Annette Lee; Fabienne Lesueur; Karen H Lu; Katherine L Nathanson; Susan L Neuhausen; Kenneth Offit; Edenir I Palmero; Priyanka Sharma; Marc Tischkowitz; Amanda E Toland; Nadine Tung; Elizabeth J van Rensburg; Ana Vega; Jeffrey N Weitzel; Gemo Study Collaborators; Kent F Hoskins; Tara Maga; Michael T Parsons; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Dezheng Huo; Olufunmilayo I Olopade; Timothy R Rebbeck
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.700

Review 5.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

Review 6.  Global Inequities in Precision Medicine and Molecular Cancer Research.

Authors:  Thomas M Drake; Stephen R Knight; Ewen M Harrison; Kjetil Søreide
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

7.  Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline.

Authors:  Aldo Germani; Fabio Libi; Stefano Maggi; Gianluca Stanzani; Augusto Lombardi; Patrizia Pellegrini; Mauro Mattei; Laura De Marchis; Claudio Amanti; Antonio Pizzuti; Maria Rosaria Torrisi; Maria Piane
Journal:  Oncotarget       Date:  2018-09-14

8.  Inherited Breast Cancer in Nigerian Women.

Authors:  Yonglan Zheng; Tom Walsh; Suleyman Gulsuner; Silvia Casadei; Ming K Lee; Temidayo O Ogundiran; Adeyinka Ademola; Adeyinka G Falusi; Clement A Adebamowo; Abideen O Oluwasola; Adewumi Adeoye; Abayomi Odetunde; Chinedum P Babalola; Oladosu A Ojengbede; Stella Odedina; Imaria Anetor; Shengfeng Wang; Dezheng Huo; Toshio F Yoshimatsu; Jing Zhang; Gabriela E S Felix; Mary-Claire King; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2018-08-21       Impact factor: 50.717

9.  Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.

Authors:  Lawal Abdulrazzaq Oluwagbemiga; Atoyebi Oluwole; Adesunkanmi Abdulrasheed Kayode
Journal:  Springerplus       Date:  2012-12-28

10.  BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.

Authors:  F Z Francies; T Wainstein; K De Leeneer; A Cairns; M Murdoch; S Nietz; H Cubasch; B Poppe; T Van Maerken; B Crombez; I Coene; R Kerr; J P Slabbert; A Vral; A Krause; A Baeyens; K B M Claes
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.